van Vugt MATM - Search Results

1

Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer.

Bense RD, Sotiriou C, Piccart-Gebhart MJ, Haanen JBAG, van Vugt MATM, de Vries EGE, Schröder CP, Fehrmann RSN. Bense RD, et al. Among authors: van vugt matm. J Natl Cancer Inst. 2016 Oct 13;109(1):djw192. doi: 10.1093/jnci/djw192. Print 2017 Jan. J Natl Cancer Inst. 2016. PMID: 27737921 Free PMC article.

2

Perspectives for tailored chemoprevention and treatment of colorectal cancer in Lynch syndrome.

Heijink DM, de Vries EG, Koornstra JJ, Hospers GA, Hofstra RM, van Vugt MA, de Jong S, Kleibeuker JH. Heijink DM, et al. Crit Rev Oncol Hematol. 2011 Nov;80(2):264-77. doi: 10.1016/j.critrevonc.2010.11.009. Epub 2010 Dec 14. Crit Rev Oncol Hematol. 2011. PMID: 21159521 Review.

3

The role of ATM and 53BP1 as predictive markers in cervical cancer.

Roossink F, Wieringa HW, Noordhuis MG, ten Hoor KA, Kok M, Slagter-Menkema L, Hollema H, de Bock GH, Pras E, de Vries EG, de Jong S, van der Zee AG, Schuuring E, Wisman GB, van Vugt MA. Roossink F, et al. Int J Cancer. 2012 Nov 1;131(9):2056-66. doi: 10.1002/ijc.27488. Epub 2012 Mar 29. Int J Cancer. 2012. PMID: 22323184 Free PMC article.

4

Toward molecular imaging-driven drug development in oncology.

de Vries EG, Oude Munnink TH, van Vugt MA, Nagengast WB. de Vries EG, et al. Cancer Discov. 2011 Jun;1(1):25-8. doi: 10.1158/2159-8274.CD-11-0051. Epub 2011 Jun 1. Cancer Discov. 2011. PMID: 22586317

5

Forced activation of Cdk1 via wee1 inhibition impairs homologous recombination.

Krajewska M, Heijink AM, Bisselink YJ, Seinstra RI, Silljé HH, de Vries EG, van Vugt MA. Krajewska M, et al. Oncogene. 2013 Jun 13;32(24):3001-8. doi: 10.1038/onc.2012.296. Epub 2012 Jul 16. Oncogene. 2013. PMID: 22797065

6

Molecular imaging for monitoring treatment response in breast cancer patients.

Bensch F, van Kruchten M, Lamberts LE, Schröder CP, Hospers GA, Brouwers AH, van Vugt MA, de Vries EG. Bensch F, et al. Eur J Pharmacol. 2013 Oct 5;717(1-3):2-11. doi: 10.1016/j.ejphar.2013.01.079. Epub 2013 Mar 30. Eur J Pharmacol. 2013. PMID: 23545359 Review.

7

CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model.

Domanska UM, Boer JC, Timmer-Bosscha H, van Vugt MA, Hoving HD, Kliphuis NM, Rosati S, van der Poel HG, de Jong IJ, de Vries EG, Walenkamp AM. Domanska UM, et al. Clin Exp Metastasis. 2014 Oct;31(7):829-39. doi: 10.1007/s10585-014-9673-2. Epub 2014 Aug 26. Clin Exp Metastasis. 2014. PMID: 25154297

8

ATR inhibition preferentially targets homologous recombination-deficient tumor cells.

Krajewska M, Fehrmann RS, Schoonen PM, Labib S, de Vries EG, Franke L, van Vugt MA. Krajewska M, et al. Oncogene. 2015 Jun;34(26):3474-81. doi: 10.1038/onc.2014.276. Epub 2014 Sep 1. Oncogene. 2015. PMID: 25174396

9

APC/C(Cdh1) controls CtIP stability during the cell cycle and in response to DNA damage.

Lafranchi L, de Boer HR, de Vries EG, Ong SE, Sartori AA, van Vugt MA. Lafranchi L, et al. EMBO J. 2014 Dec 1;33(23):2860-79. doi: 10.15252/embj.201489017. Epub 2014 Oct 27. EMBO J. 2014. PMID: 25349192 Free PMC article.

10

CXCR4 and CXCL12 Expression in Rectal Tumors of Stage IV Patients Before and After Local Radiotherapy and Systemic Neoadjuvant Treatment.

Tamas K, Domanska UM, van Dijk TH, Timmer-Bosscha H, Havenga K, Karrenbeld A, Sluiter WJ, Beukema JC, van Vugt MA, de Vries EG, Hospers GA, Walenkamp AM. Tamas K, et al. Curr Pharm Des. 2015;21(17):2276-83. doi: 10.2174/1381612821666150105155615. Curr Pharm Des. 2015. PMID: 25557636

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters